Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jul;31(4):191-199.
doi: 10.1177/1043454214532024. Epub 2014 May 5.

Evidence-Based Practice Recommendations for Hydration in Children and Adolescents With Cancer Receiving Intravenous Cyclophosphamide

Affiliations
Review

Evidence-Based Practice Recommendations for Hydration in Children and Adolescents With Cancer Receiving Intravenous Cyclophosphamide

Deborah Robinson et al. J Pediatr Oncol Nurs. 2014 Jul.

Abstract

Hemorrhagic cystitis is a known complication of cyclophosphamide, an antineoplastic agent used to treat a variety of oncologic diseases in children. Hydration can prevent hemorrhagic cystitis; however, use varies in clinical practice. A team was assembled to develop evidence-based practice recommendations to address the following question: in a population of children with cancer, what is the appropriate pre- and posthydration for the administration of different dose levels of intravenous cyclophosphamide to prevent bladder toxicity? The purpose was to identify the appropriate rate, duration, and route of hydration to prevent bladder toxicity with low, intermediate, and high dose cyclophosphamide. After a systematic search of the literature, 15 pieces of evidence were evaluated and used. There is a moderate level of quality evidence related to hydration for high dose cyclophosphamide and very low quality evidence related to intermediate or low dose cyclophosphamide. Three general recommendations were made for hydration associated with cyclophosphamide. There is a need for further research related to the prevention of bladder toxicity in children with cancer receiving cyclophosphamide.

Keywords: bladder toxicity; cancer; cyclophosphamide; hemorrhagic cystitis; pediatric.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Search Results

References

    1. Andrews J, Guyatt G, Oxman A, Alderson P, Dahm P, Falck-Ytter Y, et al. Schunemann HJ. Grade guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. Journal of Clinical Epidemiology. 2013;66:719–725. - PubMed
    1. Ballen KK, Becker P, Levebvre K, Emmons R, Lee K, Levy W, et al. Lowry P. Safety and cost of hyper hydration for the prevention of hemorrhagic cystitis in bone marrow transplant recipients. Oncology. 1999;57(4):287–292. - PubMed
    1. Children's Oncology Group. Members only website. 2013 Retrieved from https://members.childrensoncologygroup.org/
    1. Cluzeau FA, Burgers JS, Brouwers M, Grol R, Mäkelä M, Littlejohns P, et al. Hunt C. Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Quality and Safety in Health Care. 2003;12(1):18–23. - PMC - PubMed
    1. Damron BH, Brant JM, Belansky HB, Friend PJ, Samsonow S, Schaal A. Putting evidence into practice: Prevention and management of bleeding in patients with cancer. Clinical Journal of Oncology. 2009;13(5):573–583. - PubMed

MeSH terms

LinkOut - more resources